Chairman, Chief Executive Officer & President, Eli Lilly and Company
Most recently reported pay: $8.9M. No year-by-year proxy breakdown is on file — common for foreign private issuers and recently listed companies, which do not file a US proxy statement.
Names, titles and pay as reported by the company and its SEC filings, via Financial Modeling Prep. Reference only — nothing here is investment advice, and no affiliation with or endorsement by the people listed is implied.
People are taking bootleg versions of an Eli Lilly drug that isn't approved yet. Ohio wants it to stop.
Sep 14, 2026https://www.wsj.com/health/pharma/one-states-battle-to-stop-people-from-taking-unapproved-weight-loss-drugs-7e597719sentiment -0.40
Veeva Systems Sees AI as Growth Engine Beyond Its $6B 2030 Revenue Target
Sep 14, 2026https://www.marketbeat.com/instant-alerts/event-veeva-systems-sees-ai-as-growth-engine-beyond-its-6b-2030-revenue-target-2026-09-14/sentiment +0.10
Novo Nordisk May Be Poised to Outpace Eli Lilly With This Key Catalyst
Sep 13, 2026https://www.fool.com/investing/2026/09/13/novo-nordisk-may-be-poised-to-outpace-eli-lilly-wi/sentiment -0.20
Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World's First Phase III Trial of a Generative AI-Driven Innovative Drug
Sep 10, 2026https://www.prnewswire.com/news-releases/insilico-medicine-doses-first-patient-in-genesis-ipf-3-the-worlds-first-phase-iii-trial-of-a-generative-ai-driven-innovative-drug-302873749.htmlsentiment +0.20
Insilico Medicine Included in the HKEX Tech 100 Index, Drawing Attention to Opportunities in AI Value Chain
Sep 3, 2026https://www.prnewswire.com/news-releases/insilico-medicine-included-in-the-hkex-tech-100-index-drawing-attention-to-opportunities-in-ai-value-chain-302867744.htmlsentiment +0.10
Jim Cramer: This Little-Talked-About Drug Could Target the “Biggest Market of All Time” Aside From Eli Lilly's GLP-1 Drugs
Sep 1, 2026https://247wallst.com/investing/2026/09/01/jim-cramer-this-little-talked-about-drug-could-target-the-biggest-market-of-all-time-aside-from-eli-lillys-glp-1-drugs/sentiment +0.60
